Cite
HARVARD Citation
Klener, P. et al. (n.d.). Rituximab maintenance significantly prolongs progression‐free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation. American journal of hematology. 94 (2), pp. E50-E53. [Online].